Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Clinical trial NCT05786924 · RECRUITING

Trial details

NCT number: NCT05786924
Sponsor: Institut de Recherches Internationales Servier
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Histiocytic Neoplasm Histiocytosis BRAF Gene Mutation BRAF V600E BRAF V600 Mutation BRAF Mutation-Related Tumors BRAF Metastatic Lung Non-Small Cell Carcinoma Metastatic Lung Cancer Recurrent Lung Cancer Recurrent Lung Non-Small Cell Carcinoma

Start date: 2023-04-18
Primary completion: 2028-06-01
Enrollment: 554

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.